163 related articles for article (PubMed ID: 36587306)
1. Abnormal Glycosylation in Cancer Cells and Cancer Stem Cells as a Therapeutic Target.
Quader S; Tanabe S; Cabral H
Adv Exp Med Biol; 2022; 1393():141-156. PubMed ID: 36587306
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies.
Khan T; Cabral H
Front Oncol; 2021; 11():649338. PubMed ID: 33889547
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell marker glycosylation: Nature, function and significance.
Mallard BW; Tiralongo J
Glycoconj J; 2017 Aug; 34(4):441-452. PubMed ID: 28624993
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis.
Barkeer S; Chugh S; Batra SK; Ponnusamy MP
Neoplasia; 2018 Aug; 20(8):813-825. PubMed ID: 30015157
[TBL] [Abstract][Full Text] [Related]
6. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
8. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
11. An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation.
Shin KH; Kim RH
Crit Rev Oncog; 2018; 23(3-4):189-200. PubMed ID: 30311574
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
13. Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.
Luo S; Yang G; Ye P; Cao N; Chi X; Yang WH; Yan X
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740975
[TBL] [Abstract][Full Text] [Related]
14. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
17. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.
Mishra A; Pathak Y; Mishra SK; Prakash H; Tripathi V
Eur J Pharmacol; 2023 Jan; 938():175412. PubMed ID: 36427534
[TBL] [Abstract][Full Text] [Related]
18. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
